The Traderszone Network

Published in TZ Latest News 31 January, 2016 by The TZ Newswire Staff

Forget Biosimilars: It’s This Threat That Could Dent AbbVie’s Top Line

A potential approval this year of a drug that may work better than Humira could imperil sales of the company’s best-seller.